Alyeska Investment Group
AHCO icon

Alyeska Investment Group’s AdaptHealth AHCO Stock Holding History

Alyeska Investment Group’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-628,786
Closed -$23.1M – 699
2021
Q1 		$23.1M Buy
628,786
+66,298
+12% +$2.34M 0.3% 102
2020
Q4 		$21.1M Sell
562,488
-920,180
-62% -$28.5M 0.3% 107
2020
Q3 		$32.3M Buy
1,482,668
+1,459,141
+6,202% +$30.6M 0.49% 54
2020
Q2 		$379K Buy
+23,527
New +$393K 0.01% 445
2020
Q1 		– Sell
-269,457
Closed -$3.81M – 367
2019
Q4 		$2.96M Sell
269,457
-482,813
-64% -$4.8M 0.04% 264
2019
Q3 		$7.66M Hold
752,270
– – 0.11% 182
2019
Q2 		$7.62M Hold
752,270
– – 0.1% 192
2019
Q1 		$7.51M Buy
752,270
+2,267
+0.3% +$22.5K 0.1% 192
2018
Q4 		$7.37M Hold
750,003
– – 0.11% 196
2018
Q3 		$7.29M Hold
750,003
– – 0.08% 207
2018
Q2 		$7.21M Buy
+750,003
New +$7.28M 0.06% 247

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group's AHCO Position: Q2 2021 in Review

Alyeska Investment Group sold out of AdaptHealth (AHCO) in Q2 2021, closing a stake of 628,786 shares — an estimated $23.1M sold.

Alyeska Investment Group first reported a position in AHCO in Q2 2018 and held it in 11 quarters. The position peaked at $32.3M in Q3 2020. 137 funds tracked by Wall St. Rank hold AHCO as of Q2 2021.

  • Alyeska Investment Group reported no remaining AdaptHealth position as of Q2 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 628,786 AdaptHealth shares in Q2 2021, an estimated $23.1M.
  • Alyeska Investment Group first reported a position in AdaptHealth in Q2 2018 and held it in 11 quarters.
  • Alyeska Investment Group's AdaptHealth position peaked at $32.3M in Q3 2020.
  • 137 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2021.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.